Earnings summaries and quarterly performance for Integer Holdings.
Executive leadership at Integer Holdings.
Payman Khales
Detailed
President and Chief Executive Officer
CEO
DS
Diron Smith
Detailed
Executive Vice President and Chief Financial Officer
JS
Jim Stephens
Detailed
President, Cardiac Rhythm Management & Neuromodulation
JH
John Harris
Detailed
Executive Vice President, Global Operations and Manufacturing Strategy
LB
Lindsay Blackwood
Detailed
Senior Vice President, General Counsel and Corporate Secretary
Board of directors at Integer Holdings.
CC
Cheryl Capps
Detailed
Director
CM
Craig Maxwell
Detailed
Director
DS
Donald Spence
Detailed
Director
FP
Filippo Passerini
Detailed
Director
JH
James Hinrichs
Detailed
Director
JH
Jean Hobby
Detailed
Director
MC
Michael Coyle
Detailed
Director
PB
Pamela Bailey
Detailed
Chair of the Board
SA
Sheila Antrum
Detailed
Director
TJ
Tyrone Jeffers
Detailed
Director
Research analysts who have asked questions during Integer Holdings earnings calls.
RN
Richard Newitter
Truist Securities
8 questions for ITGR
Also covers: AXNX, BBNX, DXCM +19 more
SK
Suraj Kalia
Oppenheimer & Co. Inc.
8 questions for ITGR
Also covers: ABT, AORT, ATRC +14 more
NT
Nathan Treybeck
Wells Fargo Securities
7 questions for ITGR
Also covers: IRTC, LMAT, NVRO +2 more
Andrew Cooper
Raymond James
6 questions for ITGR
Also covers: AZTA, CDNA, CTKB +12 more
Brett Fishbin
KeyBanc Capital Markets
6 questions for ITGR
Also covers: ALC, COO, ICUI +7 more
Joanne Wuensch
Citigroup Inc.
6 questions for ITGR
Also covers: ABT, BAX, BDX +19 more
CB
Craig Bijou
Bank of America Securities
4 questions for ITGR
Also covers: BLCO, COO, FNA +9 more
MO
Matthew O'Brien
Piper Sandler
4 questions for ITGR
Also covers: BBNX, CNMD, DXCM +6 more
Travis Steed
Bank of America
4 questions for ITGR
Also covers: ABT, AXNX, BAX +24 more
MO
Matthew O'Brien
Piper Sandler & Co.
3 questions for ITGR
Also covers: APYX, ATEC, ATRC +18 more
BF
Brett Fishman
KeyBanc Capital Markets Inc.
2 questions for ITGR
Also covers: COO, LIVN, SHC +1 more
JL
Joanne Lynch
Citigroup Inc.
1 question for ITGR
Also covers: BSX
KS
Kristen Stewart
CL King & Associates
1 question for ITGR
Also covers: AVNS, CNMD, HAE +3 more
MO
Matt O'Brien
Piper Sandler Companies
1 question for ITGR
Also covers: BBNX, BSX, DXCM +6 more
Recent press releases and 8-K filings for ITGR.
Integer Holdings Corporation Board Under Investigation
ITGR
Legal Proceedings
Guidance Update
Demand Weakening
- Glancy Prongay Wolke & Rotter LLP announced an investigation into potential claims against the board of directors of Integer Holdings Corporation for alleged breaches of fiduciary duties to shareholders.
- The investigation follows Integer's announcement on October 23, 2025, that it reduced its full-year 2025 sales guidance to a range of $1.840 billion to $1.854 billion and anticipated 2026 net sales growth of -2% to 2%.
- Management indicated that slower market adoption of three new products, including two electrophysiology devices, was expected to lead to sales declines in 2026, causing a deceleration in Cardio & Vascular sales growth.
- Following this news, Integer's stock price fell $35.22 per share, or 32.3%, to close at $73.89 per share on October 23, 2025.
Mar 3, 2026, 5:00 PM
Integer Holdings Discusses 2026 Outlook and Strategic Priorities
ITGR
Guidance Update
Share Buyback
Demand Weakening
- Integer Holdings Corporation (ITGR) reported revenues of approximately $1.85 billion for 2025.
- For 2026, the company guided to organic sales growth of flat to up 3% and reported sales growth of flat ±1%, with adjusted EBITDA projected between -3% and +3%.
- The 2026 outlook is impacted by headwinds from three specific products, causing a 3%-4% decline, and a 1.3% inorganic headwind from a business exit. The company anticipates returning to above-market performance in 2027.
- Integer completed a $50 million share repurchase in Q4 of last year and is currently executing another $50 million advanced share repurchase program, as part of a $200 million board-authorized program.
Mar 3, 2026, 4:35 PM
Integer Holdings Reports 2025 Revenue and Provides 2026 Outlook with Anticipated Headwinds
ITGR
Guidance Update
Share Buyback
Demand Weakening
- Integer Holdings reported revenues of approximately $1.85 billion for 2025.
- The company anticipates transient headwinds in 2026 from three specific products due to lower-than-expected adoption, leading to an organic sales growth guidance of flat to up 3% and reported sales growth of flat ±1%.
- Integer expects to return to market performance in the second half of 2026 and above-market performance in 2027, supported by a robust product pipeline where product development sales have quadrupled since 2017.
- Capital management includes a $200 million share repurchase program, with $50 million completed in Q4 and an additional $50 million currently being executed.
- The company maintains a strong presence in the electrophysiology (EP) market, which is expected to grow in the mid-teens in 2026, and is also targeting growth in structural heart, neurovascular, and neuromodulation.
Mar 3, 2026, 4:35 PM
Integer Holdings Discusses 2026 Outlook and Strategic Priorities
ITGR
Guidance Update
Share Buyback
New Projects/Investments
- Integer Holdings reported approximately $1.85 billion in revenues for 2025.
- The company provided 2026 guidance for organic sales growth of flat to up 3% and adjusted EBITDA of -3% to +3%, anticipating headwinds from three specific products that are expected to cause a 3%-4% decline compared to 2025.
- Management expects to overcome these transient headwinds in 2026 and return to above-market performance in 2027, aiming for 200 basis points above market growth.
- Integer maintains a disciplined capital management approach, prioritizing organic investments and tuck-in acquisitions, and has an authorized $200 million share repurchase program, with $50 million completed in Q4 2025 and another $50 million for Q1 2026.
- The company highlights a strong and diversified product pipeline, with 80% focused on faster-growing markets such as Electrophysiology, Structural Heart, Neurovascular, and Neuromodulation, and product development sales have quadrupled since 2017.
Mar 3, 2026, 4:35 PM
Integer Holdings Corporation under investigation by Law Offices of Howard G. Smith
ITGR
Guidance Update
Legal Proceedings
Demand Weakening
- Law Offices of Howard G. Smith announced an investigation into potential breaches of fiduciary duties by the board of directors of Integer Holdings Corporation (ITGR) on behalf of investors.
- This investigation follows Integer's announcement on October 23, 2025, that it had reduced its full-year 2025 sales guidance to a range of $1.840 billion to $1.854 billion.
- The company also informed investors of anticipated net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026.
- Management revealed that sales of three new products, including two electrophysiology devices, were expected to decline in 2026 due to slower market adoption than forecasted.
- Following this news, Integer's stock price fell $35.22 per share, or 32.3%, to close at $73.89 per share on October 23, 2025.
Mar 2, 2026, 5:00 PM
Integer Holdings Corporation Under Investigation Following Guidance Reduction
ITGR
Legal Proceedings
Guidance Update
Demand Weakening
- The Law Offices of Frank R. Cruz is investigating potential claims against Integer Holdings Corporation's (ITGR) board of directors for alleged breaches of fiduciary duties to shareholders.
- This investigation follows Integer's announcement on October 23, 2025, that it reduced its full-year 2025 sales guidance to a range of $1.840 billion to $1.854 billion and anticipated lower net sales and organic sales growth for 2026.
- Management attributed the revised guidance to expected declines in sales of three new products, including two electrophysiology devices, due to slower market adoption, with the impact on Cardio & Vascular sales growth continuing into 2026.
- Following this news, Integer's stock price fell $35.22 per share, or 32.3%, to close at $73.89 per share on October 23, 2025.
Feb 26, 2026, 6:40 PM
Integer Holdings Reports Q4 and Full Year 2025 Results and Provides 2026 Outlook
ITGR
Earnings
Guidance Update
Share Buyback
Demand Weakening
- Integer Holdings reported strong Q4 2025 financial results, with sales of $472 million (up 5% on a reported basis) and Adjusted EPS of $1.76 (up 23%). For the full year 2025, sales reached $1.854 billion (up 8% on a reported basis) and Adjusted EPS was $6.40 (up 21%).
- For 2026, the company expects reported sales between $1,826 million and $1,876 million (down 1% to up 1%) and Adjusted EPS between $6.29 and $6.78 (down 2% to up 6%). This outlook includes a 3-4% headwind from lower-than-anticipated market adoption of three new products.
- Integer repurchased $50 million of common stock in Q4 2025 and announced an intention to initiate an additional $50 million accelerated share repurchase program.
- Management expressed confidence in the underlying business, which is expected to grow 4-6% in 2026 excluding the new product headwinds, and anticipates returning to 200 basis points above-market organic sales growth in 2027.
Feb 19, 2026, 2:00 PM
Integer Holdings Announces Q4 and Full Year 2025 Results and 2026 Outlook
ITGR
Earnings
Guidance Update
Share Buyback
- Integer Holdings (ITGR) reported full-year 2025 sales of $1.854 billion, an 8% increase on a reported basis, and Adjusted EPS of $6.40, up 21%. For Q4 2025, sales were $472 million (up 5% reported) and Adjusted EPS was $1.76 (up 23%).
- The company issued its 2026 financial outlook, projecting reported sales between $1,826 million and $1,876 million (down 1% to up 1%) and Adjusted EPS between $6.29 and $6.78 (down 2% to up 6%).
- This 2026 outlook includes a 3%-4% headwind from three new products with lower-than-expected market adoption; however, the underlying business is expected to grow 4%-6%.
- Integer repurchased $50 million of common stock in Q4 2025 and announced plans for an additional $50 million accelerated share repurchase program.
- Management remains confident in returning to 200 basis points above-market organic growth in 2027, driven by a strong product development pipeline.
Feb 19, 2026, 2:00 PM
Integer Holdings Announces Q4 and Full Year 2025 Results and Provides 2026 Outlook
ITGR
Earnings
Guidance Update
Share Buyback
- Integer Holdings reported strong Q4 2025 sales of $472 million (up 5% reported, 2% organic) and adjusted EPS of $1.76 (up 23%), contributing to full year 2025 sales of $1.854 billion (up 8% reported, 6% organic) and adjusted EPS of $6.40 (up 21%).
- The company announced a $50 million accelerated share repurchase program for 2026, following $50 million in share repurchases during Q4 2025.
- For full year 2026, Integer Holdings projects reported sales between $1,826 million and $1,876 million (down 1% to up 1%) and adjusted EPS between $6.29 and $6.78 (down 2% to up 6%).
- The 2026 outlook is impacted by a 3%-4% headwind from lower market adoption of three new products, though the underlying business is expected to grow 4%-6%.
- Management expressed confidence in returning to 200 basis points above-market organic growth in 2027.
Feb 19, 2026, 2:00 PM
Integer Holdings Reports Strong Q4 and Full-Year 2025 Results, Provides 2026 Outlook
ITGR
Earnings
Guidance Update
Share Buyback
- Integer Holdings reported Q4 2025 sales of $472 million, a 5% increase, and Adjusted EPS of $1.76, up 23%. Full-year 2025 sales grew 8% to $1,854 million, with Adjusted EPS rising 21% to $6.40.
- For 2026, the company projects sales between $1,826 million and $1,876 million (a change of -1% to 1%) and Adjusted EPS in the range of $6.29 to $6.78 (a change of -2% to 6%).
- While reported organic sales growth for 2026 is anticipated to be flat to up 3%, the company expects 4% to 6% organic growth when excluding select new product headwinds.
- Integer repurchased $50 million in shares during Q4 2025 and plans to initiate an approximate $50 million Accelerated Share Repurchase (ASR) program.
Feb 19, 2026, 2:00 PM
Quarterly earnings call transcripts for Integer Holdings.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more